Updated Phase III Results Reinforce Safety and Efficacy of Praxbind®
Idarucizumab immediately reversed the anticoagulant effect of dabigatran in ...

2016-11-17

文传商讯
Data on Early Onset of Efficacy for Oral OTEZLA (apremilast) in Active
ACTIVE trial in biologic-naïve patients met its primary endpoint, demon...

2016-11-16

文传商讯
ABB: Continued Margin Growth in Tough Markets
Operational EBITA margin1 increased to 12.6%White Collar Productivity on tra...

2016-10-28

文传商讯